BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Sep 9, 2017
Strategy

Some of the parts

Can Gilead apply its combination chops to make Kite CAR Ts work in solid tumors?
BioCentury | Sep 1, 2017
Company News

Gilead grabs Kite for nearly $12B

BioCentury | Aug 29, 2017
Company News

Gilead grabs Kite for nearly $12B

BioCentury | Aug 16, 2017
Distillery Therapeutics

Cancer

BioCentury | Feb 22, 2017
Company News

Gilead buys Sarepta PRV, mum on plans

BioCentury | Dec 9, 2016
Clinical News

GS-5745: Development discontinued

BioCentury | Sep 26, 2016
Clinical News

GS-5745: Phase II/III discontinued

BioCentury | Aug 11, 2016
Distillery Therapeutics

Therapeutics: Matrix metalloproteinase 9 (MMP9); netrin 1 (NTN1)

BioCentury | Jun 6, 2016
Clinical News

GS-5745: Phase I data

Items per page:
1 - 10 of 12